Sign in

CIK 0000818033 · Accelerated filer

HERON THERAPEUTICS, INC. /DE/

Sign in to watch
Ticker
HRTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
942875566
Phone
8582514400
Business address
4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO, CA, 92121
Former names
AP PHARMA INC /DE/, ADVANCED POLYMER SYSTEMS INC /DE/
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-04-30 MANHARD KIMBERLY EVP, Drug Development Other acquisition +1,529 $13.90 $21K 3,163
2021-04-15 Christian Waage Director Sale −300 $17.51 $5K 4,100
2021-04-13 Szekeres David Leslie EVP, Chief Operating Officer Option exercise +1,250 1,250
2021-04-13 Szekeres David Leslie EVP, Chief Operating Officer Shares withheld for taxes −433 $16.66 $7K 817
2021-04-13 Szekeres David Leslie EVP, Chief Operating Officer Option exercise · Restricted Stock Units −1,250 17,500
2021-04-13 Quart Barry D Chief Executive Officer Option exercise +3,646 96,155
2021-04-13 Quart Barry D Chief Executive Officer Shares withheld for taxes −963 $16.66 $16K 95,192
2021-04-13 Quart Barry D Chief Executive Officer Option exercise · Restricted Stock Units −3,646 51,041
2021-04-13 POYHONEN JOHN President & CCO Option exercise +1,250 20,847
2021-04-13 POYHONEN JOHN President & CCO Shares withheld for taxes −433 $16.66 $7K 20,414
2021-04-13 POYHONEN JOHN President & CCO Option exercise · Restricted Stock Units −1,250 17,500
2021-04-13 Peraza Lisa VP, Chief Accounting Officer Option exercise +552 12,136
2021-04-13 Peraza Lisa VP, Chief Accounting Officer Shares withheld for taxes −191 $16.66 $3K 11,945
2021-04-13 Peraza Lisa VP, Chief Accounting Officer Option exercise · Restricted Stock Units −552 7,729
2021-04-13 MANHARD KIMBERLY EVP, Drug Development Option exercise +1,250 2,067
2021-04-13 MANHARD KIMBERLY EVP, Drug Development Shares withheld for taxes −433 $16.66 $7K 1,634
2021-04-13 MANHARD KIMBERLY EVP, Drug Development Option exercise · Restricted Stock Units −1,250 17,500
2021-04-06 Johnson Craig A Director Sale −250 $17.22 $4K 3,590
2021-01-14 Szekeres David Leslie EVP, Chief Operating Officer Sale −827 $18.09 $15K 0
2021-01-13 Szekeres David Leslie EVP, Chief Operating Officer Option exercise +1,250 1,250

Page 27 of 28 · 557 trades